---
title: "West Pharmaceutical Services Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294739132.md"
description: "West Pharmaceutical Services (WST) shares rose 2.05% to $347.94, outperforming the broader market's gains but lagging behind competitors like Baxter International. This marks the stock's sixth consecutive day of gains, though it remains near its 52-week high. Trading volume was below the 50-day average."
datetime: "2026-08-03T21:04:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294739132.md)
  - [en](https://longbridge.com/en/news/294739132.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294739132.md)
generator: "portal-rs"
---

# West Pharmaceutical Services Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of West Pharmaceutical Services Inc. (WST) rose 2.05% to $347.94 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 1.48% to 7,600.50 and the Dow Jones Industrial Average rising 1.32% to 53,178.41.

This was the stock's sixth consecutive day of gains.

West Pharmaceutical Services Inc. closed 9.86% short of its 52-week high of $386.00, which the company achieved on July 23rd.

The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Abbott Laboratories (ABT) rose 1.34% to $107.12, Becton Dickinson & Co. (BDX) rose 2.77% to $170.21, and Baxter International Inc. (BAX) rose 7.42% to $28.10.

Trading volume (636,779) remained 176,743 below its 50-day average volume of 813,522.

Data source: Dow Jones Market Data, FactSet. Data compiled August 3, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-03-26 1704ET

### Related Stocks

- [WST.US](https://longbridge.com/en/quote/WST.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [ABT.US](https://longbridge.com/en/quote/ABT.US.md)
- [BDX.US](https://longbridge.com/en/quote/BDX.US.md)
- [BAX.US](https://longbridge.com/en/quote/BAX.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [Mitsubishi UFJ Asset Management Co. Ltd. Makes New $67.58 Million Investment in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/296465296.md)
- [Is West Pharmaceutical Services (WST) Undervalued After Its Run to $349.42?](https://longbridge.com/en/news/295995196.md)
- [Redwood Investment Management LLC Makes New Investment in West Pharmaceutical Services, Inc. $WST](https://longbridge.com/en/news/294799024.md)
- [Pacira BioSciences CMO Jonathan Slonin sells 3,040 shares for $70,619.20](https://longbridge.com/en/news/296271811.md)
- [Analyst Reiterates Buy on West as Biologics-Driven Double-Digit Growth, Margin Upside and Conservative Outlook Signal Further Upside Potential](https://longbridge.com/en/news/293625778.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**